In the patients with liver metastases tested for BRAF mutations in both the tumor tissue and plasma (n = 405), the kappa coefficient was 0.91 (95% CI: 0.81–1.00) and the accuracy was 98.6% (95% CI: 96.5–99.6%). This evidence concerns the gene BRAF and neoplasm.